SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18600390
Source:
http://linkedlifedata.com/resource/pubmed/id/18600390
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019169
,
umls-concept:C0021311
,
umls-concept:C0021747
,
umls-concept:C0026882
,
umls-concept:C0205466
,
umls-concept:C0209738
,
umls-concept:C0871261
,
umls-concept:C1704632
,
umls-concept:C1706817
,
umls-concept:C2349975
,
umls-concept:C2911692
pubmed:issue
6
pubmed:dateCreated
2008-7-7
pubmed:abstractText
The virologic impact of adding interferon to antiviral nucleoside therapy was studied in Japanese patients having perinatally transmitted hepatitis B virus (HBV) genotype C.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9430794
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine
,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Core Proteins
pubmed:status
MEDLINE
pubmed:issn
0944-1174
pubmed:author
pubmed-author:HikijiKazumasaK
,
pubmed-author:KatoMichioM
,
pubmed-author:NagaokaTakayukiT
,
pubmed-author:NukuiKazuhikoK
,
pubmed-author:OmuraMasaoM
,
pubmed-author:YukiNobukazuN
pubmed:issnType
Print
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
457-63
pubmed:meshHeading
pubmed-meshheading:18600390-Adult
,
pubmed-meshheading:18600390-Aged
,
pubmed-meshheading:18600390-Antiviral Agents
,
pubmed-meshheading:18600390-DNA, Viral
,
pubmed-meshheading:18600390-Drug Therapy, Combination
,
pubmed-meshheading:18600390-Female
,
pubmed-meshheading:18600390-Hepatitis B, Chronic
,
pubmed-meshheading:18600390-Hepatitis B virus
,
pubmed-meshheading:18600390-Humans
,
pubmed-meshheading:18600390-Interferon-alpha
,
pubmed-meshheading:18600390-Lamivudine
,
pubmed-meshheading:18600390-Male
,
pubmed-meshheading:18600390-Middle Aged
,
pubmed-meshheading:18600390-Mutation
,
pubmed-meshheading:18600390-Viral Core Proteins
pubmed:year
2008
pubmed:articleTitle
Adding interferon to lamivudine enhances the early virologic response and reversion of the precore mutation in difficult-to-treat HBV infection.
pubmed:affiliation
Department of Gastroenterology, Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka 540-0006, Japan.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Randomized Controlled Trial